share_log

片倉工業:連結子会社における中性脂肪蓄積心筋血管症治療薬「CNT-01」の国内第2b3相臨床試験解析結果(速報)のお知らせ

Katakura Industries: Announcements of individual stocks: Analysis results of domestic Phase 2b/3 clinical trial of "CNT-01", a therapeutic drug for neutral lipid accumulation cardiac vascular disease, in the consolidated subsidiary (preliminary report).

JPX ·  Jun 25 03:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more